US officials link tariffs with drug pricing talksnews2025-08-26T19:53:10+00:00August 26th, 2025|Endpoints News|
Vinay Prasad drops two of his titles in return to FDAnews2025-08-26T19:20:49+00:00August 26th, 2025|Endpoints News|
Lilly plans GLP-1 pill filing after trial success in obesity and diabetesnews2025-08-26T10:45:53+00:00August 26th, 2025|Endpoints News|
HHS winds down decades-old pediatric brain cancer collaborationnews2025-08-25T19:39:28+00:00August 25th, 2025|Endpoints News|
Overall survival in cancer drug trials: New FDA draft guidance sets the barnews2025-08-25T18:20:37+00:00August 25th, 2025|Endpoints News|
FDA begins publishing adverse event data on a daily basisnews2025-08-25T17:55:29+00:00August 25th, 2025|Endpoints News|
FDA suspends license for Valneva’s chikungunya vaccine amid safety concernsnews2025-08-25T12:18:59+00:00August 25th, 2025|Endpoints News|
Biohaven won’t face FDA advisory committee meeting for its SCA drugnews2025-08-22T15:43:44+00:00August 22nd, 2025|Endpoints News|
CDC staff won’t serve as members of ACIP’s new Covid-19 working groupnews2025-08-21T19:49:54+00:00August 21st, 2025|Endpoints News|
